Total
0
Shares
Isracann (CSE:IPOT) to import cannabis from major Israeli manufacturer
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Fiore Cannabis (FIOR) has sold its B.C. asset to redouble its focus on the U.S. market in Nevada and California
  • The company terminated the letter of intent signed with Indigenomix International dated April 8, 2020
  • It has subsequently signed a memorandum of understanding with PECA Properties to transfer ownership of its Celista, B.C. asset and subsidiaries
  • The Celista asset includes 40 acres of land, two constructed buildings and a late-stage Health Canada License to Cultivate application
  • The transaction enables Fiore to eliminate C$4.8 million in long-term liabilities
  • Fiore Cannabis has been developing medical and recreational cannabis products since 2014
  • Fiore (FIOR) closed the day up 10 per cent trading at $0.165 per share

Fiore Cannabis (FIOR) has sold its B.C. asset to redouble its focus on the U.S. market in Nevada and California.

The company terminated the letter of intent signed with Indigenomix International dated April 8, 2020.

It has subsequently signed a memorandum of understanding with PECA Properties to transfer ownership of Fiore's Celista, B.C. asset, as well as its wholly-owned subsidiaries, Marapharm and Full Spectrum Medicinal, in consideration for debt and liabilities.

The Celista asset includes 40 acres of land, two constructed buildings and a late-stage Health Canada License to Cultivate application.

The transaction enables Fiore to eliminate C$4.8 million in long-term liabilities.

Erik Anderson, President and CEO of Fiore Cannabis, commented,

"We are very pleased to have completed the sale of the Celista asset as it does not fit with the company's strategic direction. The transaction further cleans up our balance sheet and will enable us to allocate additional funds to drive expansion in our key markets of Nevada and California.

We continue to expand upon our operations in Las Vegas and the Coachella Valley and focus our energies on where we are generating revenues and profitability."

Furthering its strategy, the company has terminated two additional LOIs in British Columbia. The first was to purchase a micro cultivation facility, Laughing Turtle Farms, dated October 6, 2020. The second was to purchase two retail cannabis locations from 1260474 B.C. Ltd. dated October 8, 2020.

Fiore Cannabis has been developing medical and recreational cannabis products since 2014.

Fiore (FIOR) closed the day up 10 per cent trading at $0.165 per share.

More From The Market Herald
EnWave - CEO, Brent Charleton. - The Market Herald Canada

" EnWave (TSXV:ENW) signs license agreement with major U.S. cannabis operator

EnWave (ENW) has signed a royalty-bearing license with the second-largest U.S. cannabis multi-state operator.
Cultivation begins at TransCanna’s (CSE:TCAN) first crop management site

" Cultivation begins at TransCanna’s (CSE:TCAN) first crop management site

Plants are going into TransCanna’s (TCAN) first crop management site today – a greenhouse in Wesley, California.
Sprout AI (CSE:SPRT) receives $2.1 million purchase order

" Sprout AI (CSE:SPRT) announces initial sales order

Sprout AI (SPRT) has been selected by JT Medical to provide cultivation technology for controlled substances.
TransCanna (CSE:TCAN) achieves milestone with its first harvest at Daly Facility

" TransCanna (CSE:TCAN) achieves milestone with its first harvest at Daly Facility

TransCanna (TCAN) has completed its first harvest at its Daly Facility, marking a major milestone for the company.